Bioverativ taps patient social network for input on hemophilia trial design
admin 24th August 2017 Uncategorised 0What if companies knew patients’ top unmet needs before they began clinical trials and could factor them into studies—potentially paving the way for marketers to talk up a variety of benefits down the line? Bioverativ is about to find out.
More: Bioverativ taps patient social network for input on hemophilia trial design
Source: fierce